GlassScriptPhysician profile
Carlos Smith
NPI 1992724538
$543.27
in general payments reported to CMS, 2019-2025
10 companies · $39.66 in 2025
The $39.66 reported for 2025 was less than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.58 · 2021: $122 · 2023: $206 · 2024: $159 · 2025: $39.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $405.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $134.92 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Vifor Pharma, INC. | $122.40 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $121.84 | 2024 | Andexxa |
| Integra Lifesciences Corporation | $39.66 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Stryker Corporation | $37.41 | 2024 | Ortholoc 2 Lapifuse |
| Pfizer INC. | $26.04 | 2023 | |
| Novo Nordisk INC | $22.11 | 2023 | Wegovy |
| Becton, Dickinson and Company | $15.58 | 2019 | |
| Philips North America LLC | $13.50 | 2023 | |
| Penumbra, INC. | $9.81 | 2023 | Indigo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carlos Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.